STOCK TITAN

[Form 4] Procter & Gamble Company Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Form 4 highlights (filed 7 Aug 2025): Procter & Gamble’s Chief Research, Development & Innovation Officer, Moses V. J. Aguilar, disclosed routine equity accruals delivered through company compensation plans—no open-market trading occurred.

  • New awards: 780 Restricted Stock Units (RSUs) granted on 08/07/2025; 12.5783 dividend-equivalent RSUs credited 05/15/2025; 0.6323 shares of Series A preferred stock credited 07/14/2025 via retirement plan.
  • Cost: All issuances at $0, classified as code “A” (award) with “V” modifier, indicating non-discretionary, benefit-plan transactions.
  • Post-transaction holdings: Direct ownership—25,351.0828 common shares plus 877.6365 RSUs; Indirect—6,750.7456 common shares and 1,782.2509 preferred shares held by plan trustees.
  • RSUs and preferred shares convert to PG common stock upon retirement or plan distribution per plan rules.

No sales, dispositions, or market purchases were reported; the filing does not materially alter insider ownership percentage or signal a directional view on PG’s share price.

Riepilogo del Modulo 4 (presentato il 7 agosto 2025): Moses V. J. Aguilar, Chief Research, Development & Innovation Officer di Procter & Gamble, ha comunicato accantonamenti azionari di routine derivanti dai piani di compensazione aziendali, senza operazioni di compravendita sul mercato aperto.

  • Nuove assegnazioni: 780 Unità Azionarie Vincolate (RSU) concesse il 07/08/2025; 12,5783 RSU equivalenti a dividendi accreditate il 15/05/2025; 0,6323 azioni privilegiate di Serie A accreditate il 14/07/2025 tramite piano pensionistico.
  • Costo: Tutte le emissioni a costo zero, classificate come codice “A” (assegnazione) con modificatore “V”, a indicare transazioni non discrezionali legate a piani di beneficio.
  • Detenzioni post-transazione: Proprietà diretta – 25.351,0828 azioni ordinarie più 877,6365 RSU; Indiretta – 6.750,7456 azioni ordinarie e 1.782,2509 azioni privilegiate detenute dai fiduciari del piano.
  • Le RSU e le azioni privilegiate si convertono in azioni ordinarie PG al momento del pensionamento o della distribuzione secondo le regole del piano.

Non sono state segnalate vendite, cessioni o acquisti sul mercato; la comunicazione non modifica in modo significativo la percentuale di proprietà degli insider né indica una posizione sul prezzo delle azioni PG.

Aspectos destacados del Formulario 4 (presentado el 7 de agosto de 2025): Moses V. J. Aguilar, Director de Investigación, Desarrollo e Innovación de Procter & Gamble, informó sobre acumulaciones rutinarias de acciones entregadas a través de los planes de compensación de la empresa, sin operaciones en el mercado abierto.

  • Nuevas adjudicaciones: 780 Unidades de Acciones Restringidas (RSU) otorgadas el 07/08/2025; 12,5783 RSU equivalentes a dividendos acreditadas el 15/05/2025; 0,6323 acciones preferentes Serie A acreditadas el 14/07/2025 mediante plan de retiro.
  • Costo: Todas las emisiones a costo $0, clasificadas con código “A” (adjudicación) y modificador “V”, indicando transacciones no discrecionales de planes de beneficios.
  • Participaciones tras la transacción: Propiedad directa – 25,351.0828 acciones comunes más 877.6365 RSU; Indirecta – 6,750.7456 acciones comunes y 1,782.2509 acciones preferentes en fideicomiso del plan.
  • Las RSU y las acciones preferentes se convierten en acciones comunes de PG al momento de la jubilación o distribución según las reglas del plan.

No se reportaron ventas, disposiciones ni compras en el mercado; la presentación no altera materialmente el porcentaje de propiedad de los insiders ni señala una postura sobre el precio de las acciones de PG.

양식 4 주요 내용 (2025년 8월 7일 제출): Procter & Gamble의 최고 연구개발 혁신 책임자 모세스 V. J. 아길라르는 회사 보상 계획을 통해 정기적으로 주식을 적립했음을 공시했으며, 공개 시장 거래는 없었습니다.

  • 신규 수여: 2025년 8월 7일에 780개의 제한 주식 단위(RSU) 부여; 2025년 5월 15일에 12.5783개의 배당금 상당 RSU 적립; 2025년 7월 14일에 퇴직 연금 계획을 통해 0.6323주의 A 시리즈 우선주 적립.
  • 비용: 모든 발행은 $0로 처리되었으며, 'A' 코드(수여)와 'V' 수정자가 붙어 비재량적 복리후생 계획 거래임을 나타냄.
  • 거래 후 보유: 직접 보유 – 25,351.0828 보통주 및 877.6365 RSU; 간접 보유 – 플랜 수탁자가 보유한 6,750.7456 보통주 및 1,782.2509 우선주.
  • RSU와 우선주는 퇴직 또는 플랜 분배 시 플랜 규정에 따라 PG 보통주로 전환됨.

판매, 처분 또는 시장 매수 보고 없음; 제출 내용은 내부자 소유 지분에 중대한 변동을 주지 않으며 PG 주가에 대한 방향성 신호도 아님.

Points clés du formulaire 4 (déposé le 7 août 2025) : Moses V. J. Aguilar, Directeur de la Recherche, du Développement et de l’Innovation chez Procter & Gamble, a déclaré des attributions d’actions régulières dans le cadre des plans de rémunération de l’entreprise, sans opérations sur le marché libre.

  • Nouvelles attributions : 780 unités d’actions restreintes (RSU) accordées le 07/08/2025 ; 12,5783 RSU équivalentes à des dividendes créditées le 15/05/2025 ; 0,6323 actions privilégiées de série A créditées le 14/07/2025 via un plan de retraite.
  • Coût : Toutes les émissions à coût nul, classées code « A » (attribution) avec le modificateur « V », indiquant des transactions non discrétionnaires liées à un plan d’avantages.
  • Détentions après transaction : Détention directe – 25 351,0828 actions ordinaires plus 877,6365 RSU ; Détention indirecte – 6 750,7456 actions ordinaires et 1 782,2509 actions privilégiées détenues par les fiduciaires du plan.
  • Les RSU et actions privilégiées se convertissent en actions ordinaires PG lors du départ à la retraite ou de la distribution selon les règles du plan.

Aucune vente, cession ou achat sur le marché n’a été signalé ; le dépôt ne modifie pas de manière significative la part détenue par les initiés ni n’indique une position sur le cours de l’action PG.

Formular 4 Highlights (eingereicht am 7. August 2025): Moses V. J. Aguilar, Chief Research, Development & Innovation Officer von Procter & Gamble, meldete routinemäßige Aktienansammlungen im Rahmen von Unternehmensvergütungsplänen – kein Handel am offenen Markt fand statt.

  • Neue Zuteilungen: 780 Restricted Stock Units (RSUs) am 07.08.2025 gewährt; 12,5783 Dividendenäquivalente RSUs am 15.05.2025 gutgeschrieben; 0,6323 Aktien der Serie A Vorzugsaktien am 14.07.2025 über den Altersvorsorgeplan gutgeschrieben.
  • Kosten: Alle Emissionen zum Preis von 0 $, klassifiziert als Code „A“ (Zuteilung) mit dem Modifikator „V“, was auf nicht diskretionäre, leistungsbezogene Transaktionen hinweist.
  • Bestände nach der Transaktion: Direkter Besitz – 25.351,0828 Stammaktien plus 877,6365 RSUs; Indirekt – 6.750,7456 Stammaktien und 1.782,2509 Vorzugsaktien, gehalten von Treuhändern des Plans.
  • RSUs und Vorzugsaktien werden bei Renteneintritt oder Planverteilung gemäß Planregeln in Stammaktien von PG umgewandelt.

Keine Verkäufe, Veräußerungen oder Markttransaktionen gemeldet; die Meldung verändert den Insider-Besitzanteil nicht wesentlich und signalisiert keine Richtung für den Aktienkurs von PG.

Positive
  • None.
Negative
  • None.

Insights

TL;DR — Routine plan-based awards; neutral for valuation.

The transactions are automatic grants tied to dividend reinvestment and retirement benefits, representing <0.001% of PG’s float. There is no cash outlay by the insider and no open-market activity, so they neither indicate bullish conviction nor raise governance concerns. Such filings are common for senior executives at large-cap issuers and carry de minimis market impact.

Riepilogo del Modulo 4 (presentato il 7 agosto 2025): Moses V. J. Aguilar, Chief Research, Development & Innovation Officer di Procter & Gamble, ha comunicato accantonamenti azionari di routine derivanti dai piani di compensazione aziendali, senza operazioni di compravendita sul mercato aperto.

  • Nuove assegnazioni: 780 Unità Azionarie Vincolate (RSU) concesse il 07/08/2025; 12,5783 RSU equivalenti a dividendi accreditate il 15/05/2025; 0,6323 azioni privilegiate di Serie A accreditate il 14/07/2025 tramite piano pensionistico.
  • Costo: Tutte le emissioni a costo zero, classificate come codice “A” (assegnazione) con modificatore “V”, a indicare transazioni non discrezionali legate a piani di beneficio.
  • Detenzioni post-transazione: Proprietà diretta – 25.351,0828 azioni ordinarie più 877,6365 RSU; Indiretta – 6.750,7456 azioni ordinarie e 1.782,2509 azioni privilegiate detenute dai fiduciari del piano.
  • Le RSU e le azioni privilegiate si convertono in azioni ordinarie PG al momento del pensionamento o della distribuzione secondo le regole del piano.

Non sono state segnalate vendite, cessioni o acquisti sul mercato; la comunicazione non modifica in modo significativo la percentuale di proprietà degli insider né indica una posizione sul prezzo delle azioni PG.

Aspectos destacados del Formulario 4 (presentado el 7 de agosto de 2025): Moses V. J. Aguilar, Director de Investigación, Desarrollo e Innovación de Procter & Gamble, informó sobre acumulaciones rutinarias de acciones entregadas a través de los planes de compensación de la empresa, sin operaciones en el mercado abierto.

  • Nuevas adjudicaciones: 780 Unidades de Acciones Restringidas (RSU) otorgadas el 07/08/2025; 12,5783 RSU equivalentes a dividendos acreditadas el 15/05/2025; 0,6323 acciones preferentes Serie A acreditadas el 14/07/2025 mediante plan de retiro.
  • Costo: Todas las emisiones a costo $0, clasificadas con código “A” (adjudicación) y modificador “V”, indicando transacciones no discrecionales de planes de beneficios.
  • Participaciones tras la transacción: Propiedad directa – 25,351.0828 acciones comunes más 877.6365 RSU; Indirecta – 6,750.7456 acciones comunes y 1,782.2509 acciones preferentes en fideicomiso del plan.
  • Las RSU y las acciones preferentes se convierten en acciones comunes de PG al momento de la jubilación o distribución según las reglas del plan.

No se reportaron ventas, disposiciones ni compras en el mercado; la presentación no altera materialmente el porcentaje de propiedad de los insiders ni señala una postura sobre el precio de las acciones de PG.

양식 4 주요 내용 (2025년 8월 7일 제출): Procter & Gamble의 최고 연구개발 혁신 책임자 모세스 V. J. 아길라르는 회사 보상 계획을 통해 정기적으로 주식을 적립했음을 공시했으며, 공개 시장 거래는 없었습니다.

  • 신규 수여: 2025년 8월 7일에 780개의 제한 주식 단위(RSU) 부여; 2025년 5월 15일에 12.5783개의 배당금 상당 RSU 적립; 2025년 7월 14일에 퇴직 연금 계획을 통해 0.6323주의 A 시리즈 우선주 적립.
  • 비용: 모든 발행은 $0로 처리되었으며, 'A' 코드(수여)와 'V' 수정자가 붙어 비재량적 복리후생 계획 거래임을 나타냄.
  • 거래 후 보유: 직접 보유 – 25,351.0828 보통주 및 877.6365 RSU; 간접 보유 – 플랜 수탁자가 보유한 6,750.7456 보통주 및 1,782.2509 우선주.
  • RSU와 우선주는 퇴직 또는 플랜 분배 시 플랜 규정에 따라 PG 보통주로 전환됨.

판매, 처분 또는 시장 매수 보고 없음; 제출 내용은 내부자 소유 지분에 중대한 변동을 주지 않으며 PG 주가에 대한 방향성 신호도 아님.

Points clés du formulaire 4 (déposé le 7 août 2025) : Moses V. J. Aguilar, Directeur de la Recherche, du Développement et de l’Innovation chez Procter & Gamble, a déclaré des attributions d’actions régulières dans le cadre des plans de rémunération de l’entreprise, sans opérations sur le marché libre.

  • Nouvelles attributions : 780 unités d’actions restreintes (RSU) accordées le 07/08/2025 ; 12,5783 RSU équivalentes à des dividendes créditées le 15/05/2025 ; 0,6323 actions privilégiées de série A créditées le 14/07/2025 via un plan de retraite.
  • Coût : Toutes les émissions à coût nul, classées code « A » (attribution) avec le modificateur « V », indiquant des transactions non discrétionnaires liées à un plan d’avantages.
  • Détentions après transaction : Détention directe – 25 351,0828 actions ordinaires plus 877,6365 RSU ; Détention indirecte – 6 750,7456 actions ordinaires et 1 782,2509 actions privilégiées détenues par les fiduciaires du plan.
  • Les RSU et actions privilégiées se convertissent en actions ordinaires PG lors du départ à la retraite ou de la distribution selon les règles du plan.

Aucune vente, cession ou achat sur le marché n’a été signalé ; le dépôt ne modifie pas de manière significative la part détenue par les initiés ni n’indique une position sur le cours de l’action PG.

Formular 4 Highlights (eingereicht am 7. August 2025): Moses V. J. Aguilar, Chief Research, Development & Innovation Officer von Procter & Gamble, meldete routinemäßige Aktienansammlungen im Rahmen von Unternehmensvergütungsplänen – kein Handel am offenen Markt fand statt.

  • Neue Zuteilungen: 780 Restricted Stock Units (RSUs) am 07.08.2025 gewährt; 12,5783 Dividendenäquivalente RSUs am 15.05.2025 gutgeschrieben; 0,6323 Aktien der Serie A Vorzugsaktien am 14.07.2025 über den Altersvorsorgeplan gutgeschrieben.
  • Kosten: Alle Emissionen zum Preis von 0 $, klassifiziert als Code „A“ (Zuteilung) mit dem Modifikator „V“, was auf nicht diskretionäre, leistungsbezogene Transaktionen hinweist.
  • Bestände nach der Transaktion: Direkter Besitz – 25.351,0828 Stammaktien plus 877,6365 RSUs; Indirekt – 6.750,7456 Stammaktien und 1.782,2509 Vorzugsaktien, gehalten von Treuhändern des Plans.
  • RSUs und Vorzugsaktien werden bei Renteneintritt oder Planverteilung gemäß Planregeln in Stammaktien von PG umgewandelt.

Keine Verkäufe, Veräußerungen oder Markttransaktionen gemeldet; die Meldung verändert den Insider-Besitzanteil nicht wesentlich und signalisiert keine Richtung für den Aktienkurs von PG.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Aguilar Moses Victor Javier

(Last) (First) (Middle)
ONE PROCTER AND GAMBLE PLAZA

(Street)
CINCINNATI OH 45202

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
PROCTER & GAMBLE Co [ PG ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chf Rsch, Dev & Innov Officer
3. Date of Earliest Transaction (Month/Day/Year)
08/07/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 25,351.0828(1) D
Common Stock 6,750.7456(2) I By Retirement Plan Trustee
Common Stock 428.6033 I International Stock Ownership Plan (Mexico) Trustee
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (3) 05/15/2025 A V 12.5783 (4) (4) Common Stock 12.5783 $0 97.6365 D
Series A Preferred Stock (5) 07/14/2025 A V 0.6323 (6) (6) Common Stock 0.6323 $0 1,782.2509 I By Retirement Plan Trustee
Restricted Stock Units (7) 08/07/2025 A 780 (4) (4) Common Stock 780 $0 780 D
Explanation of Responses:
1. Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock and shares acquired through the issuer's dividend reinvestment plan.
2. Reflects adjustment to PST through July 14, 2025.
3. Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock.
4. These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account.
5. Higher of $6.82 (adjusted for 2-for-1 stock split effective May 21, 2004) or market price of Common Stock.
6. Shares held by Retirement Plan Trustees. If Officer terminates employment and elects distribution of shares, or, if after age 50 elects alternative investment within Plan, Preferred Stock converted/redeemed at specified conversion/exercise price.
7. Retirement award in the form of Restricted Stock Units which represent a contingent right to receive P&G common stock or cash settlement. Amount and price computed per benefit formula for plan year ended 6/30/2025.
/s/ Wednesday Shipp, attorney-in-fact for Mr. Aguilar Moses 08/07/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did PG insider Moses Aguilar report in the 7 Aug 2025 Form 4?

He received 780 RSUs, 12.5783 dividend-equivalent RSUs, and 0.6323 Series A preferred shares under company plans; no shares were sold.

How many Procter & Gamble shares does Aguilar now own?

After the awards he directly owns 25,351.0828 common shares and 877.6365 RSUs, plus indirect holdings via benefit plans.

Were any PG shares sold in this filing?

No. The Form 4 shows only acquisitions (code “A”); there were no dispositions or open-market sales.

What was the purchase price of the RSUs and preferred shares?

All awards were issued at $0 as part of compensation and dividend programs.

Do these transactions signal insider confidence in PG stock?

Because they are automatic, plan-based grants, they are generally viewed as neutral indicators rather than active insider buying.
Procter & Gamble

NYSE:PG

PG Rankings

PG Latest News

PG Latest SEC Filings

PG Stock Data

358.05B
2.34B
0.06%
70.11%
0.63%
Household & Personal Products
Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics
Link
United States
CINCINNATI